Fontan 候选资格提前判定:聚焦解剖与生理变量
单中心回顾性队列研究纳入 1998 至 2021 年行心外管道 Fontan 姑息术患者,按手术体重分为 <12 kg(n=30)与 ≥12 kg(n=175)两组。两组术前血流动力学相当,<12 kg 组术后肺血管阻力更高(2.59 WU vs 1.78 WU;
要点
- 经多学科评估后,部分体重 <12 kg 的单心室患儿可安全完成 Fontan 姑息术。
- 管道尺寸达标是独立于体重的重要结局决定因素。
核心结论
- 在经多学科判定候选资格的选择性患者中,体重 <12 kg 行 Fontan 姑息术可安全完成,支持以解剖与生理变量替代严格体重阈值的策略。
- 体重 <12 kg 患者术后肺血管阻力更高,尽管临床结局与 ≥12 kg 组相当,仍需纵向随访。
- 获得满意的管道尺寸是独立于体重的重要结局决定因素。
研究设计与样本
- 单中心高容量中心回顾性队列研究,纳入 1998 至 2021 年行心外管道 Fontan 姑息术患者。
- 经多学科判定 Fontan 候选资格后,按手术体重分为 <12 kg 组(n=30)与 ≥12 kg 组(n=175)。
- 比较两组 Fontan 术前与术后血流动力学、管道尺寸及术后结局。
主要发现
- 两组术前血流动力学相当。
- 30 天结局包括 Fontan 失败、住院时间和死亡率在两组间相当。
- 中位随访 7.5 年,两组在生存、心脏移植需求和主要并发症方面无显著差异。
关键数值与推荐
- 体重分层阈值为手术时 <12 kg 与 ≥12 kg。
- 中位随访时间为 7.5 年。
临床怎么用
- Fontan 候选资格判定可结合解剖与生理变量,而非仅依赖体重阈值。
- 对体重 <12 kg 的选定患者,经多学科评估后可考虑早期 Fontan 姑息术。
- 术后应关注肺血管阻力,尤其是低体重患者,并进行纵向随访。
- 管道尺寸达标是独立于体重的重要考量,应予以重视。
局限性
- 回顾性单中心研究设计。
- <12 kg 组样本量较小(n=30)。
- 研究结果来自单一高容量中心,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Timing and patient selection for Fontan palliation in single-ventricle congenital heart disease remain subjects of debate. An early Fontan procedure can limit long-term morbidity after total cavopulmonary connection, yet patient-specific anatomic and physiologic variables may limit candidacy. Weight thresholds are often applied to anticipate physiologic tolerance and acceptable achievable conduit size. The purpose of this study was to evaluate outcomes within a single, high-volume center by using anatomic and physiologic variables rather than a weight threshold for Fontan candidacy. METHODS: A retrospective cohort study was conducted on patients undergoing extracardiac conduit Fontan palliation between 1998 and 2021. After multidisciplinary determination of Fontan candidacy, patients were stratified by weight at surgery: <12 kg (n = 30) and ≥12 kg (n = 175). Pre- and post-Fontan hemodynamics, conduit size, and postoperative outcomes were compared. RESULTS: Preoperative hemodynamics were comparable between the groups. Postoperatively, patients weighing <12 kg had higher pulmonary vascular resistance (2.59 WU vs 1.78 WU; P = .005), yet 30-day outcomes, including Fontan failure, length of stay, and mortality, were comparable. At a median follow-up of 7.5 years, there were no significant differences in survival, need for heart transplantation, or major complications. Smaller conduits in patients ≥12 kg were associated with increased protein-losing enteropathy (P = .046). CONCLUSIONS: Fontan palliation can be safely performed in select patients weighing <12 kg, a finding supporting a strategy based on anatomic and physiologic variables over a strict weight threshold. Despite comparable clinical outcomes, higher pulmonary vascular resistance in smaller patients warrants longitudinal follow-up. Achievement of a satisfactory conduit size remains an important consideration and determinant of outcomes independent of weight.
引用
- Zakrzewski J, Drysdale N, Leahy R, et al. Earlier Fontan Candidacy Determination: A Focus on Anatomic and Physiologic Variables. Ann Thorac Surg. 2025. PMID: 41067605. doi:10.1016/j.athoracsur.2025.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。